(Q35152606)

6 August 2017

1 reference

title

Predicting long-term survival in multiple myeloma patients following autotransplants (English)

1 reference

6 August 2017

1 reference

2

Frits Van Rhee

1 reference

6 August 2017

author name string

Athanasios B T Fassas

series ordinal

1

1 reference

6 August 2017

Guido Tricot

series ordinal

3

1 reference

6 August 2017

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

44

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

749-758

1 reference

VAD-based regimens as primary treatment for multiple myeloma

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

VAD chemotherapy as remission induction for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Results of autologous stem cell transplant in multiple myeloma patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

The role of stem cell transplantation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Prognostic value of cytogenetics in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Karyotype in multiple myeloma and plasma cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

DNA and RNA flow cytometric study in multiple myeloma. Clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. Castelano-Leonés (Spain) Cooperative Group for the Study of Monoclonal Gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Hypodiploidy is a major prognostic factor in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Cytogenetic findings in 200 patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000067567

10.1080/1042819031000067567

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference